Summary: Signifier Medical Technologies announced its largest order to date, with Spectrum Sleep Solutions ordering 10,000 units of the eXciteOSA device following South Carolina’s Medicaid coverage approval. The eXciteOSA device uses neuromuscular electrical stimulation for a non-invasive treatment of obstructive sleep apnea.
Key Takeaways:
- Largest Order: Signifier received its largest order of 10,000 eXciteOSA units from Spectrum Sleep Solutions.
- Medicaid Approval: The order follows South Carolina’s Medicaid coverage approval for the eXciteOSA device.
- Non-Invasive Therapy: eXciteOSA offers a non-invasive alternative to traditional sleep apnea treatments, using neuromuscular electrical stimulation.
Signifier Medical Technologies announced its largest order to date for its sleep apnea therapy device eXciteOSA device, with home medical provider Spectrum Sleep Solutions Inc placing an order for 10,000 units.
The order follows South Carolina’s Medicaid coverage approval for the therapy. The device will be covered without prior authorization for full-benefit Healthy Connections Medicaid members aged 18 years or older. Eligible members must have a diagnosis of mild OSA, indicated by a sleep study, with a score of apnea-hypopnea index of more than five and less than 15.
Non-Invasive Therapy
eXciteOSA offers a non-invasive approach to treating obstructive sleep apnea. eXciteOSA uses neuromuscular electrical stimulation therapy to build the endurance of the muscles at the back of the tongue, reducing the risk of airway collapse during sleep.
Over 15,000 patients have been prescribed eXciteOSA, and real-world data demonstrate strong adherence of patients using therapy over 80% of days. Patients complete sessions for 20 minutes during the day.
Spectrum Sleep Solutions’ CEO Forrest Ackerman says in a release, “This partnership with Signifier represents a major step in our commitment to offering innovative and effective solutions for sleep apnea and treating hundreds of thousands of patients who are in need of successful and clinically proven alternative therapies for sleep-disordered breathing. The eXciteOSA therapy provides a non-invasive alternative that aligns with our mission to improve patient outcomes and overall quality of life.”
Broadening Access to Sleep Apnea Treatment
Akhil Tripathi, Signifier’s founder and director, says in a release, “Coming off the back of the recent Medicaid coverage in South Carolina, this milestone reflects our ongoing mission to broaden access to innovative therapies for individuals in need. Spectrum Sleep Solutions, a leading healthcare distributor in the US, shares Signifier’s vision for eXciteOSA becoming the de-facto first-line therapy in the treatment of sleep apnea and is the first of a sequence of related transactions that Spectrum Sleep Solutions has pledged as they continue to deepen their relationship with the company.”
Photo caption: exciteOSA
Photo credit: Signifer Medical Technologies/file
Leave a Reply